The lupus nephritis treatment market is anticipated to develop at a compound annual growth rate (CAGR) of 11% from 2023 to 2033, from its present value of US$ 1.8 billion in 2022 to US$ 5.67 billion by 2033. The rise in the market can be attributed to several factors, including the rising incidence of the …